Shaaltiel Yoseph

Director at Protalix BioTherapeutics, Inc. · on record since Jan 5, 2007
Executive VP, R&D at Protalix BioTherapeutics, Inc. · on record since Jan 5, 2007

Insider trading activity of Shaaltiel Yoseph

Transactions on record: 34; since Jan 5, 2007

Open-market buys: 7; $97.8K

Open-market sells: 17; $7.2M

Companies traded: 1; last filing Sep 14, 2018

Figures computed from official regulatory filings — methodology.

Companies where Shaaltiel Yoseph has traded

Protalix BioTherapeutics, Inc.34 tx · $7.3M · Sep 14, 2018

Track record of Shaaltiel Yoseph

Statistical track record

Free

Open-market buys: 7

Last buy: Dec 19, 2007

Win rates and median returns are available with a free account (5 insiders/month).

Create a free account

Transaction history of Shaaltiel Yoseph

Co-insiders of Shaaltiel Yoseph

Akirov AlfredProtalix BioTherapeutics, Inc.
Almon Einat BrillProtalix BioTherapeutics, Inc.
Altschuler StevenProtalix BioTherapeutics, Inc.
Aviezer DavidProtalix BioTherapeutics, Inc.
Bar-Shalev AmosProtalix BioTherapeutics, Inc.
Bashan DrorProtalix BioTherapeutics, Inc.
Beck Joanne T.Protalix BioTherapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Protalix BioTherapeutics, Inc.	Sep 14, 2018	AwardD	700,000	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Sep 16, 2016	ExerciseD	-122,162	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Sep 16, 2016	Exercise	122,162	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	May 7, 2015	AwardD	275,000	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Jul 18, 2012	Award	210,000	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	May 4, 2012	Sell	-300,000	7.13 USD	$2.1M	SEC
Protalix BioTherapeutics, Inc.	Aug 9, 2010	Sell	-48,408	7.00	$338.9K	SEC
Protalix BioTherapeutics, Inc.	Aug 9, 2010	Sell	-4,619	7.00	$32.3K	SEC
Protalix BioTherapeutics, Inc.	Jun 23, 2010	Sell	-52,973	7.00	$370.8K	SEC
Protalix BioTherapeutics, Inc.	May 3, 2010	Sell	-12,691	7.00	$88.8K	SEC
Protalix BioTherapeutics, Inc.	Apr 16, 2010	Sell	-1,309	7.00	$9.2K	SEC
Protalix BioTherapeutics, Inc.	Mar 25, 2010	Sell	-127,300	7.02	$893.6K	SEC
Protalix BioTherapeutics, Inc.	Mar 25, 2010	Sell	-202,700	7.08	$1.4M	SEC
Protalix BioTherapeutics, Inc.	Mar 25, 2010	Sell	-50,000	7.00	$350K	SEC
Protalix BioTherapeutics, Inc.	Feb 26, 2010	AwardD	145,000	0.00	$0	SEC
Protalix BioTherapeutics, Inc.	Oct 19, 2009	Sell	-43,120	9.43	$406.6K	SEC
Protalix BioTherapeutics, Inc.	Oct 19, 2009	Sell	-25,680	9.39	$241.1K	SEC
Protalix BioTherapeutics, Inc.	Oct 19, 2009	Sell	-31,200	9.39	$293K	SEC
Protalix BioTherapeutics, Inc.	Jul 8, 2009	Sell	-80,000	5.13	$410.4K	SEC
Protalix BioTherapeutics, Inc.	Jul 8, 2009	Sell	-20,000	4.95	$99K	SEC
Protalix BioTherapeutics, Inc.	May 20, 2009	Sell	-20,000	3.51	$70.2K	SEC
Protalix BioTherapeutics, Inc.	May 20, 2009	Sell	-10,000	3.85	$38.5K	SEC
Protalix BioTherapeutics, Inc.	Mar 13, 2009	Sell	-8,300	2.18	$18.1K	SEC
Protalix BioTherapeutics, Inc.	Feb 27, 2009	AwardD	50,000	0.00	$0	SEC
Protalix BioTherapeutics, Inc.	Feb 13, 2008	AwardD	263,728	0.00	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Protalix BioTherapeutics, Inc.	Sep 14, 2018	AwardD	700,000	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Sep 16, 2016	ExerciseD	-122,162	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Sep 16, 2016	Exercise	122,162	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	May 7, 2015	AwardD	275,000	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Jul 18, 2012	Award	210,000	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	May 4, 2012	Sell	-300,000	7.13 USD	$2.1M	SEC
Protalix BioTherapeutics, Inc.	Aug 9, 2010	Sell	-48,408	7.00	$338.9K	SEC
Protalix BioTherapeutics, Inc.	Aug 9, 2010	Sell	-4,619	7.00	$32.3K	SEC
Protalix BioTherapeutics, Inc.	Jun 23, 2010	Sell	-52,973	7.00	$370.8K	SEC
Protalix BioTherapeutics, Inc.	May 3, 2010	Sell	-12,691	7.00	$88.8K	SEC
Protalix BioTherapeutics, Inc.	Apr 16, 2010	Sell	-1,309	7.00	$9.2K	SEC
Protalix BioTherapeutics, Inc.	Mar 25, 2010	Sell	-127,300	7.02	$893.6K	SEC
Protalix BioTherapeutics, Inc.	Mar 25, 2010	Sell	-202,700	7.08	$1.4M	SEC
Protalix BioTherapeutics, Inc.	Mar 25, 2010	Sell	-50,000	7.00	$350K	SEC
Protalix BioTherapeutics, Inc.	Feb 26, 2010	AwardD	145,000	0.00	$0	SEC
Protalix BioTherapeutics, Inc.	Oct 19, 2009	Sell	-43,120	9.43	$406.6K	SEC
Protalix BioTherapeutics, Inc.	Oct 19, 2009	Sell	-25,680	9.39	$241.1K	SEC
Protalix BioTherapeutics, Inc.	Oct 19, 2009	Sell	-31,200	9.39	$293K	SEC
Protalix BioTherapeutics, Inc.	Jul 8, 2009	Sell	-80,000	5.13	$410.4K	SEC
Protalix BioTherapeutics, Inc.	Jul 8, 2009	Sell	-20,000	4.95	$99K	SEC
Protalix BioTherapeutics, Inc.	May 20, 2009	Sell	-20,000	3.51	$70.2K	SEC
Protalix BioTherapeutics, Inc.	May 20, 2009	Sell	-10,000	3.85	$38.5K	SEC
Protalix BioTherapeutics, Inc.	Mar 13, 2009	Sell	-8,300	2.18	$18.1K	SEC
Protalix BioTherapeutics, Inc.	Feb 27, 2009	AwardD	50,000	0.00	$0	SEC
Protalix BioTherapeutics, Inc.	Feb 13, 2008	AwardD	263,728	0.00	$0	SEC